ClinicalTrials.Veeva

Menu

Single-implant Versus Two-implant Mandibular Overdentures

R

Rola Shadid

Status

Enrolling

Conditions

Edentulism

Treatments

Procedure: Two-implant mandibular overdenture (interforaminal)
Procedure: Single-implant mandibular overdenture (parasymphyseal/canine region)

Study type

Interventional

Funder types

Other

Identifiers

NCT07408778
AAUP IRB Ref: J-2025A/46/N.

Details and patient eligibility

About

This randomized controlled trial compares a mandibular overdenture retained by one implant placed in the parasymphyseal or canine region with a mandibular overdenture retained by two implants placed in the interforaminal region in completely edentulous adults. Primary outcomes are oral health-related quality of life, patient satisfaction, and masticatory performance measured by a two-color chewing gum mixing test, assessed at baseline before implant surgery and at 3, 6, and 12 months after overdenture insertion.

Full description

Eligible completely edentulous adults will be randomized to receive either one endosseous implant in the mandibular parasymphyseal or canine region on the preferred chewing side or two endosseous implants in the mandibular interforaminal region, followed by restoration with a locator-type attachment retained mandibular overdenture. Oral health-related quality of life, patient satisfaction, and masticatory performance assessed by a two-color chewing gum mixing test are collected at baseline before surgery and at 3, 6, and 12 months after overdenture insertion. Secondary outcomes include postoperative pain recorded during the early postoperative period, radiographic marginal bone level change, peri-implant clinical parameters, prosthetic maintenance events, and clinician chair time from implant surgery through overdenture insertion.

Enrollment

32 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women ≥40 years.
  • ASA I-II; favorable general health or adequately controlled systemic disease (e.g., hypertension, diabetes).
  • Skeletal Class I relationship.
  • Completely edentulous mandible and maxilla.
  • Technically acceptable complete dentures in both jaws for ≥3 and ≤24 months; dissatisfaction limited to mandibular retention/stability.
  • Adequate anterior mandibular bone for implant ≥3.5×10 mm confirmed on CBCT; no bone augmentation needed.
  • Normal mucosal resilience (~2 mm displacement).
  • Implant sites healed ≥4 months since extraction.
  • Willingness to be randomized and attend follow-ups; written informed consent.
  • Primary stability target ≥25 N-cm.

Exclusion criteria

  • Uncontrolled systemic disease; neurodegenerative disease; osteoporosis requiring antiresorptives.
  • Chronic systemic antibiotics/steroids; bleeding disorders; active cancer therapy; metabolic bone disease; HIV.
  • Investigational drug use within 30 days.
  • Alcohol dependence/illicit drug use; xerostomia (stimulated flow <0.7 mL/min).
  • Heavy smoking >20 cigarettes/day.
  • TMD/orofacial pain; severe bruxism; moderate/severe cognitive impairment.
  • Prior implant therapy.
  • Non-adherence risk or inability to attend longitudinal visits.
  • Insufficient prosthetic space for attachment housing: inter-arch vertical distance <8.5 mm at parasymphyseal/canine region.
  • Concurrent participation in another interventional study.
  • Erosive lichen planus or other significant oral mucosal disease; head-and-neck irradiation history.
  • Mandibular pathology on CBCT (e.g., cyst, tumor).
  • Ridge dimensions <6 mm width or <10 mm height at planned sites.
  • Active intraoral infection.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups

Single-implant mandibular overdenture (parasymphyseal/canine, preferred chewing side)
Experimental group
Description:
One bone-level implant will be placed in the mandibular parasymphyseal/canine region on the preferred chewing side using a single-stage approach. A locator-type attachment (Sonator S) will be connected according to the manufacturer's instructions, and intraoral pick-up will be performed with cold-curing resin.
Treatment:
Procedure: Single-implant mandibular overdenture (parasymphyseal/canine region)
Two-implant mandibular overdenture (interforaminal)
Active Comparator group
Description:
Two bone-level implants will be placed bilaterally in the mandibular interforaminal region (bilateral lateral incisor-canine area) using a single-stage approach. Locator-type attachments (Sonator S) will be connected according to the manufacturer's instructions, and intraoral pick-up will be performed with cold-curing resin.
Treatment:
Procedure: Two-implant mandibular overdenture (interforaminal)

Trial contacts and locations

1

Loading...

Central trial contact

Jafar AbuAssba, BDS, MSc; Rola M Shadid, BDS, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems